UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

The Radiobiology of Proton Therapy: Challenges and Opportunities Around Relative Biological Effectiveness

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-05, Vol.30 (5), p.285-292

2018

Volltextzugriff (PDF)

A Brief Overview of the Preclinical and Clinical Radiobiology of Microbeam Radiotherapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-11, Vol.33 (11), p.705-712

2021

Volltextzugriff (PDF)

Robustness of differential gene expression analysis of RNA-seq

Computational and structural biotechnology journal, 2021-01, Vol.19, p.3470-3481

2021

Volltextzugriff (PDF)

Multidisciplinary European Low Dose Initiative (MELODI): strategic research agenda for low dose radiation risk research

Radiation and environmental biophysics, 2018-03, Vol.57 (1), p.5-15

2018

Volltextzugriff (PDF)

Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy

Biochemical pharmacology, 2008-07, Vol.76 (1), p.19-27

2008

Volltextzugriff (PDF)

Novel unconventional radiotherapy techniques: Current status and future perspectives – Report from the 2nd international radiation oncology online seminar

Clinical and translational radiation oncology, 2023-05, Vol.40, p.100605-100605, Article 100605

2023

Volltextzugriff (PDF)

Bystander Signalling: Exploring Clinical Relevance Through New Approaches and New Models

Clinical oncology (Royal College of Radiologists (Great Britain)), 2013-10, Vol.25 (10), p.586-592

2013

Volltextzugriff (PDF)

EP-1751: Time-resolved analysis of Varian RPM-gated exposures on three versions of Truebeam linac

Radiotherapy and oncology, 2016-04, Vol.119, p.S820-S820

2016

Volltextzugriff (PDF)

PO-0739: Plasma citrulline is a potential biomarker for small bowel toxicity following radiotherapy for prostate cancer

Radiotherapy and oncology, 2015-04, Vol.115, p.S366-S366

2015

Volltextzugriff (PDF)

SP-0504: Preclinical radiotherapy technology, dosimetry and treatment planning

Radiotherapy and oncology, 2016-04, Vol.119, p.S238-S239

2016

Volltextzugriff (PDF)

62 MeV Proton beams induced DNA damage in hypoxic conditions

Radiotherapy and oncology, 2016-02, Vol.118, p.S24-S24

2016

Volltextzugriff (PDF)

Investigating the impact of a variable RBE on proton dose fractionation across an actively scanned spread-out Bragg peak

Radiotherapy and oncology, 2016-02, Vol.118, p.S87-S88

2016

Volltextzugriff (PDF)

89 The HDAC Inhibitor Vorinostat Down-regulates c-FLIP and Sensitizes Human Non-small Cell Lung Carcinoma Cell Lines to Ionising Radiation

European journal of cancer (1990), 2012-11, Vol.48, p.28-28

2012

Volltextzugriff (PDF)

Laser accelerated ultra high dose rate protons induced DNA damage under hypoxic conditions

Radiotherapy and oncology, 2016-02, Vol.118, p.S24-S25

2016

Volltextzugriff (PDF)

1132 The HDAC Inhibitor Vorinostat (SAHA) Down-regulates C-FLIP and Sensitizes Human Non-small Cell Lung Carcinoma Cell Lines to Ionising Radiation

European journal of cancer (1990), 2012-07, Vol.48, p.S272-S273

2012

Volltextzugriff (PDF)

Impact of 4-Dimensional CT (4D-CT) on Toxicity, Outcomes, and Dose Escalation for Radical Lung Cancer Radiation Therapy

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S517-S517

2013

Volltextzugriff (PDF)

OC-0286: Radiobiological implications of respiratory motion in the treatment of lung cancer

Radiotherapy and oncology, 2013-03, Vol.106, p.S111-S111

2013

Volltextzugriff (PDF)

Investigating the Potential Impact of Four-dimensional Computed Tomography (4DCT) on Toxicity, Outcomes and Dose Escalation for Radical Lung Cancer Radiotherapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2014-03, Vol.26 (3), p.142-150

2014

Volltextzugriff (PDF)

OC-0075: Investigation of the radiobiological implications of respiratory gating in vitro for non-small cell lung cancer

Radiotherapy and oncology, 2014, Vol.111, p.S28-S29

2014

Volltextzugriff (PDF)

Differential Mechanisms of Cellular Radiobiological Response Following Exposure to Intensity Modulated Radiation Fields

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S672-S672

2012

Volltextzugriff (PDF)

EP-1574 MODELLING EFFECTS OF INTERCELLULAR COMMUNICATION ON CELL SURVIVAL AFTER MODULATED RADIATION EXPOSURE

Radiotherapy and oncology, 2012-05, Vol.103, p.S603-S604

2012

Volltextzugriff (PDF)

161: RBE and DNA damage variation along monoenergetic and modulated Bragg peaks of a 62 MeV therapeutic protons beam

Radiotherapy and oncology, 2014-02, Vol.110, p.S79-S79

2014

Volltextzugriff (PDF)

Is There an Association Between the Location of the Dominant Intraprostatic Lesion and Biochemical/Clinical Failure Following Treatment with LDR Prostate Brachytherapy?

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e537-e537

2024

Volltextzugriff (PDF)

PO-1574: Robustness of CT-based prostate radiomics features against artefacts from gold fiducial markers

Radiotherapy and oncology, 2020-11, Vol.152, p.S853-S854

2020

Volltextzugriff (PDF)

A potential biomarker of radiosensitivity in metastatic hormone sensitive prostate cancer patients treated with combination external beam radiotherapy and radium-223

Radiotherapy and oncology, 2024-02, Vol.191, p.110063-110063, Article 110063

2024

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(75)
Buchkapitel
(4)

Sprache

Englisch
(79)
Japanisch
(14)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Radiobiology of Proton Therapy: Challenges and Opportunities Around Relative Biological Effectiveness

A Brief Overview of the Preclinical and Clinical Radiobiology of Microbeam Radiotherapy

Robustness of differential gene expression analysis of RNA-seq

Multidisciplinary European Low Dose Initiative (MELODI): strategic research agenda for low dose radiation risk research

Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy

Novel unconventional radiotherapy techniques: Current status and future perspectives – Report from the 2nd international radiation oncology online seminar

Bystander Signalling: Exploring Clinical Relevance Through New Approaches and New Models

EP-1751: Time-resolved analysis of Varian RPM-gated exposures on three versions of Truebeam linac

PO-0739: Plasma citrulline is a potential biomarker for small bowel toxicity following radiotherapy for prostate cancer

SP-0504: Preclinical radiotherapy technology, dosimetry and treatment planning

62 MeV Proton beams induced DNA damage in hypoxic conditions

Investigating the impact of a variable RBE on proton dose fractionation across an actively scanned spread-out Bragg peak

89 The HDAC Inhibitor Vorinostat Down-regulates c-FLIP and Sensitizes Human Non-small Cell Lung Carcinoma Cell Lines to Ionising Radiation

Laser accelerated ultra high dose rate protons induced DNA damage under hypoxic conditions

1132 The HDAC Inhibitor Vorinostat (SAHA) Down-regulates C-FLIP and Sensitizes Human Non-small Cell Lung Carcinoma Cell Lines to Ionising Radiation

Impact of 4-Dimensional CT (4D-CT) on Toxicity, Outcomes, and Dose Escalation for Radical Lung Cancer Radiation Therapy

OC-0286: Radiobiological implications of respiratory motion in the treatment of lung cancer

Investigating the Potential Impact of Four-dimensional Computed Tomography (4DCT) on Toxicity, Outcomes and Dose Escalation for Radical Lung Cancer Radiotherapy

OC-0075: Investigation of the radiobiological implications of respiratory gating in vitro for non-small cell lung cancer

Differential Mechanisms of Cellular Radiobiological Response Following Exposure to Intensity Modulated Radiation Fields

EP-1574 MODELLING EFFECTS OF INTERCELLULAR COMMUNICATION ON CELL SURVIVAL AFTER MODULATED RADIATION EXPOSURE

161: RBE and DNA damage variation along monoenergetic and modulated Bragg peaks of a 62 MeV therapeutic protons beam

Is There an Association Between the Location of the Dominant Intraprostatic Lesion and Biochemical/Clinical Failure Following Treatment with LDR Prostate Brachytherapy?

PO-1574: Robustness of CT-based prostate radiomics features against artefacts from gold fiducial markers

A potential biomarker of radiosensitivity in metastatic hormone sensitive prostate cancer patients treated with combination external beam radiotherapy and radium-223

Suchergebnisse filtern